Key Highlights
•
Exosomes from fat-derived stem cells carry a molecule called miR-449b-5p that can calm overactive airway muscle cells in children with asthma. This finding points to a potential new cell-free therapy that could reduce inflammation and improve breathing without the side effects of traditional drugs.
Source →
•
The therapeutic molecule works by targeting and turning down a specific receptor (IGF1R) on airway muscle cells, which stops the cells from multiplying too quickly and contracting excessively. This reveals a precise molecular mechanism that could be targeted to develop more effective treatments for asthma.
Source →
Stay curious. Stay informed — with
Science Briefing.
Always double check the original article for accuracy.
